Genentech (DNA) Joins The 52-Week Low Club
Genentech (DNA) Big biopharma drops on poort clinical trial results for its drug Avastin. Down to $75.56 from 52-week high of $89.73. Verasun Energy (VSE) Rise in supply of ethanol could hurt margins. Shares drop to $14.36 from 52-week high…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Genentech (DNA) Big biopharma drops on poort clinical trial results for its drug Avastin. Down to $75.56 from 52-week high of $89.73.
Verasun Energy (VSE) Rise in supply of ethanol could hurt margins. Shares drop to $14.36 from 52-week high of $30.75.
Northwest Air (NWA) Just out of Chapter 11. Not a nice reception as oil prices hurt airline shares. Down to $23.85 just a few days from emerging. The high since then is $26.50.
Spatialight (HDTV) Bad news about largest customer and delisting keep dogging it. Down to $.07 from $3.10.
Transmeta (TMTA) Chip maker has unhealthy loss in latest quarter. Drops to $.28 from 52-week high of $1.75.
Mannkind (MNKD) Drug development firm had rought quarter. Down to $10.18 from 52-week high of $21.74.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.
